Acceso abierto

Pneumonitis with amivantamab in squamous cell lung cancer with EGFR exon 20 insertion mutation: a case report

Margarida Melo Cruz

Margarida Melo Cruz

Serviço de Pneumologia, ULS Trás-os-Montes e Alto DouroVila Real, Portugal
Buscar este autor en
Sciendo|Google Scholar
Cruz, Margarida Melo
, 
Ana Filipa Silva

Ana Filipa Silva

Serviço de Pneumologia, ULS Trás-os-Montes e Alto DouroVila Real, Portugal
Buscar este autor en
Sciendo|Google Scholar
Silva, Ana Filipa
, 
Sara Raimundo

Sara Raimundo

Serviço de Pneumologia, ULS Trás-os-Montes e Alto DouroVila Real, Portugal
Buscar este autor en
Sciendo|Google Scholar
Raimundo, Sara
 y 
Teresa Gomes

Teresa Gomes

Serviço de Pneumologia, ULS Trás-os-Montes e Alto DouroVila Real, Portugal
Buscar este autor en
Sciendo|Google Scholar
Gomes, Teresa
  
04 dic 2024
Pneumonitis with amivantamab in squamous cell lung cancer with EGFR exon 20 insertion mutation: a case report's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Categoría del artículo: Research Article
Publicado en línea: 04 dic 2024
Páginas: 39 - 42
Recibido: 16 abr 2024
Aceptado: 03 jul 2024
DOI: https://doi.org/10.2478/fco-2023-0039
Palabras clave
© 2024 Margarida Melo Cruz et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1:

CT scan at diagnosis showing a right upper lobe lesion with right upper and medium lobes collapse.
CT scan at diagnosis showing a right upper lobe lesion with right upper and medium lobes collapse.

Figure 2:

CT scan after treatment with amivantamab showing scattered ground glass opacities in the left lung.
CT scan after treatment with amivantamab showing scattered ground glass opacities in the left lung.

Figure 3:

CT scan after corticosteroid treatment showing resolution of the previous opacities.
CT scan after corticosteroid treatment showing resolution of the previous opacities.

Figure 4:

CT scan after reintroduction of amivantamab, without evidence of toxicity and stable disease.
CT scan after reintroduction of amivantamab, without evidence of toxicity and stable disease.
Idioma:
Inglés
Calendario de la edición:
2 veces al año
Temas de la revista:
Medicina, Medicina Clínica, Medicina Interna, Hematología, oncología
RSS Feed de revista